Commentary
In order to compare the outcomes of the two diagnostic criteria in a population-based study, Q. Huang et al. (Peking University People’s Hospital, Beijing, China) aimed to investigate the association of MAFLD or NAFLD with all-cause and cause-specific mortality. They recruited 12,480 participants from the Third National Health and Nutrition Examination Survey (NHANES III) with matched mortality data in 2015.
MAFLD patients “showed greater risk for all-cause mortality and equal risk for cause-specific mortality referring to NAFLD. The new terminology excluded participants with lower mortality risk and included participants with higher risk.”
Hepatic inflammatory responses in liver fibrosis